Welcome to our dedicated page for Owens & Minor news (Ticker: OMI), a resource for investors and traders seeking the latest updates and insights on Owens & Minor stock.
Owens & Minor, Inc. (NYSE: OMI) generates a steady flow of corporate, financial, and strategic news as it transitions into Accendra Health, Inc. and refocuses on home-based care. Company press releases and SEC filings describe a multi-step transformation that includes the sale of its Products & Healthcare Services (P&HS) segment, a shift toward a pure play home-based care platform centered on the Patient Direct business, and a corporate name and ticker change to Accendra Health, Inc. and ACH on the New York Stock Exchange.
News related to OMI has recently covered transaction announcements, such as the definitive agreement and subsequent completion of the sale of the P&HS segment to an affiliate of Platinum Equity, along with details of the retained equity stake and associated tax attributes. Earnings releases provide quarterly and year-to-date financial results for continuing operations, which primarily represent the Patient Direct segment and certain functional operations, and discuss management’s views on the company’s financial outlook and strategic priorities.
Investors and observers will also find corporate governance and leadership updates in the news flow, including executive appointments, role changes, and amendments to executive compensation and retirement plans that are connected to the company’s evolving structure. Additional items include announcements of participation in investor conferences, where management presents the company’s strategy and financial profile, and commercial agreements such as the national preferred DME network arrangement involving Apria and Byram with Optum Health.
This news page for OMI serves as a historical archive of Owens & Minor’s communications as it moves toward operating as Accendra Health, Inc. under the ACH ticker. Readers can use it to trace the company’s shift from a combination of hospital-focused distribution and home-based care toward a focused Patient Direct platform, as well as to follow key regulatory filings, transaction milestones, and strategic announcements.
Owens & Minor has successfully completed its acquisition of Apria for approximately
Owens & Minor, Inc. (NYSE: OMI) has announced the upsize and pricing of its private offering of $600 million in senior notes, increasing the size by $100 million. The 6.625% notes due 2030 will close on March 29, 2022. Proceeds will finance the acquisition of Apria, Inc. and repay Apria's debt, with excess funds for corporate purposes. The notes are offered only to qualified institutional buyers and are not registered under the Securities Act.
Owens & Minor, Inc. (NYSE:OMI) has launched a private offering of $500 million in senior notes due 2030, aimed at financing its upcoming acquisition of Apria, Inc. The offering's proceeds will initially be held in escrow until certain conditions are met. The acquisition is contingent upon the approval of a majority of Apria shareholders. The notes will be offered only to qualified institutional buyers and are not registered under federal securities laws. The company intends to use net proceeds for acquisition-related expenses and general corporate purposes, highlighting its commitment to growth in healthcare solutions.
Owens & Minor (NYSE: OMI) has announced a $500,000 donation of medical-grade PPE to support healthcare efforts in
Owens & Minor, Inc. (NYSE: OMI) will present at the Barclays Global Healthcare Conference on March 15, 2022, at 2:35 PM ET. The presentation by CEO Ed Pesicka will be available via live webcast, accessible through the company's investor relations section on its website. Owens & Minor is a leading global healthcare solutions provider, facilitating a seamless supply of surgical and PPE products across North America, Asia, Europe, and Latin America since 1882. The company serves over 4,000 healthcare customers with a dedicated team of 15,000.
Owens & Minor, Inc. (NYSE: OMI) will participate in J.P. Morgan’s High Yield & Leveraged Finance Conference on February 28, 2022. CEO Ed Pesicka will present at the event. Access to the presentation can be found on Owens & Minor's investor relations website. The company specializes in global healthcare solutions, manufacturing and distributing surgical and PPE products, and serves a wide range of healthcare customers. Established in 1882, it operates globally with a significant focus in the Americas.
Owens & Minor, Inc. (NYSE: OMI) announces the appointment of Kenny Gardner, Chief People Officer at DaVita, to its Board of Directors effective March 1, 2022. Gardner brings nearly 20 years of healthcare experience and expertise in process innovation and talent strategies. His role at DaVita included overseeing benefits and diversity initiatives for over 65,000 employees. The selection aligns with Owens & Minor's multi-year succession planning, and Gardner will be nominated for re-election at the upcoming annual shareholder meeting on April 29, 2022.
Owens & Minor (NYSE-OMI) reported a strong finish in 2021, with a record adjusted net income of $61.2 million for Q4 and $309.3 million for the full year, demonstrating robust growth. The company's 2022 revenue guidance is set between $9.2 billion and $9.6 billion, even as it anticipates a revenue decline of $400-$450 million due to normalizing glove costs. The Apria acquisition is on track to enhance its Patient Direct services, expected to close by mid-2022. The firm also reported a 5% revenue growth in Q4, driven by strong performance in the Patient Direct business.
Owens & Minor, Inc. (NYSE: OMI) will participate in Citi’s 2022 Virtual Healthcare Conference on February 24, 2022. Ed Pesicka, President and CEO, will engage in a fireside chat with analysts at approximately 12:30 PM ET. The event will be webcast live and accessible on the company’s website under investor relations.
Owens & Minor is a global healthcare solutions provider, supporting over 4,000 customers with innovative technology and self-manufactured products.
Owens & Minor, Inc. (NYSE: OMI) will release its financial results for the fourth quarter and full year of 2021 on February 23, 2022, prior to market open. A conference call will follow at 8:30 a.m. ET on the same day to discuss the results. Participants can join via dial-in or a webcast available on the company's website. With over 15,000 employees, Owens & Minor has established a significant presence in global healthcare solutions since its inception in 1882.
FAQ
What is the current stock price of Owens & Minor (OMI)?
What is the market cap of Owens & Minor (OMI)?
